Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Stop Addiction Stigma [NA]
This is a completed clinical trial update (NCT06582030) from Ohio State University Comprehensive Cancer Center, related to hematologic malig…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating SPH3348 tablets, a C-Met inhibitor, in patients with advanced solid tumors has completed. The update does not inclu…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer [Phase 1, Phase 2]
A clinical trial update indicates the APG-2575 study for breast cancer and solid tumors (Phase 1/Phase 2) has been suspended by sponsor Asce…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients [NA]
A completed clinical trial update describes using DX600 labeled for PET imaging to target ACE2 in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies [Phase 1]
Phase 1 study evaluating safety, tolerability and preliminary efficacy of an erythrocyte-anchored PD-1 conjugate in patients with advanced m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Food Effect on Pharmacokinetics and Safety of DHP107 (Liporaxel®) FEEL Study [Phase 1]
Phase 1 FEEL study evaluating the effect of food on the pharmacokinetics and safety of DHP107 (Liporaxel) in patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies [Phase 1]
Phase 1 trial update reporting safety and preliminary efficacy data for ATG-017 as monotherapy or in combination with nivolumab in patients …
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 trial update of SHR-A1921 in subjects with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Validating Pain Scales in Children and Young Adults
National Cancer Institute completed a clinical trial focused on validating pain scales in children and young adults with sickle cell disease…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Study of SRF617 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating SRF617 in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations [Phase 2]
A Phase 2 study of Ulixertinib in patients with advanced solid tumors harboring MEK or atypical BRAF alterations was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors [Phase 1]
Pfizer's Phase 1 trial of PF-07901800 (TTI-621) in patients with hematologic malignancies and selected solid tumors was terminated, with res…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates [Phase 1]
Phase 1 pharmacokinetic study to assess potential drug-drug interactions and QTc effects between sitravatinib and a substrate cocktail has b…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of GNX102 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study of GNX102 in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of SYNB1891 alone or with atezolizumab in adults with metastatic solid tumors or lymp…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases [Phase 4]
Phase 4 clinical trial assessing a dual time-point FDG PET/MRI protocol to improve imaging of brain metastases; trial status is completed.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 trial evaluating ATG-019, a dual PAK4 and NAMPT inhibitor, in advanced solid tumors or Non-Hodgkin's lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Study of AK119 in Subjects With Advanced Solid Tumors [Phase 1]
The Phase 1 study of AK119 in subjects with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Merestinib In Non-Small Cell Lung Cancer And Solid Tumors [Phase 2]
Phase 2 trial update for merestinib in non-small cell lung cancer and solid tumors; study terminated with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of repotrectinib in combination with other anticancer therapies for KRAS-mutant solid tumors has been terminated with result…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for a study evaluating safety, efficacy, and pharmacokinetics in participants with advanced solid tumors, including re…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies [Phase 2]
Phase 2 trial of poziotinib in EGFR or HER2 activating mutations across advanced malignancies was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: PTX-35 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for PTX-35 in patients with advanced solid tumors; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours [Phase 1, Phase 2]
Clinical trial update for ZG2001 in KRAS-mutated advanced solid tumors in Phase 1/2 cohorts.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for intravenous T3011 as a single agent and in combination therapy in advanced solid tumors including hepatocellular c…